abstract |
The present invention relates to a compound represented by the following formula (wherein R 1 to R 6 , R 10 , Y, n, m, p, and q are as defined in the specification). The compounds and compositions of the invention are useful for the treatment of diseases associated with overexpression of CCR2. |